Digest Network Come funziona
Network
/
Società
CY
Non verificato

CYBIN Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

12 comunicati stampa

Guarda tutti i comunicati
04/09/2024
Scienza
Biotecnologia
Farmaceutica
Medicina alternativa
Salute
Psichiatria
Medicina - Varie
Eventi
Web e Social Network
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
27/08/2024
Biotecnologia
Igiene alimentare
Psichiatria
Salute
Medicina - Varie
Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
13/08/2024
Biotecnologia
Igiene alimentare
Psichiatria
Salute
Medicina - Varie
Industria
Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
08/08/2024
Medicina alternativa
Psichiatria
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Mercato azionario
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
07/08/2024
Medicina alternativa
Psichiatria
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Eventi
Web e Social Network
Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
26/06/2024
Web e Social Network
Telefonia e Varie
Mercato azionario
Psichiatria
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Medicina alternativa
Salute
Farmaceutica
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
19/06/2024
Biotecnologia
Psichiatria
Medicina alternativa
Salute
Farmaceutica
Web e Social Network
Eventi
Fiere
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
11/06/2024
Medicina alternativa
Salute
Sanità
Farmaceutica
Biotecnologia
Mercato del lavoro
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
29/05/2024
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Medicina alternativa
Salute
Psichiatria
Medicina - Varie
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
14/05/2024
Media
Marketing
Comunicazione
Medicina - Varie
Multimedialità
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0